Literature DB >> 17283093

Mice lacking CD21 and CD35 proteins mount effective immune responses against Borrelia burgdorferi infection.

Amanda C Jacobson1, Ying Ma, James F Zachary, Janis J Weis, John H Weis.   

Abstract

CD21/35(-/-) mice, deficient in CD21 and CD35 (complement receptors 2 and 1, respectively), were infected with Borrelia burgdorferi to assess the role of these receptors in a chronic bacterial infection. Although CD21/35(-/-) mice on both C57BL/6 and BALB/c backgrounds produced less B. burgdorferi-specific antibodies than did wild-type mice, spirochete levels and arthritis severity were similar.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283093      PMCID: PMC1865699          DOI: 10.1128/IAI.01920-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi.

Authors:  Chad S Brooks; Santosh R Vuppala; Amy M Jett; Antti Alitalo; Seppo Meri; Darrin R Akins
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses.

Authors:  Karen M Haas; Minoru Hasegawa; Douglas A Steeber; Jonathan C Poe; Mark D Zabel; Cheryl B Bock; David R Karp; David E Briles; John H Weis; Thomas F Tedder
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

Review 3.  Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes.

Authors:  R M Wooten; J J Weis
Journal:  Curr Opin Microbiol       Date:  2001-06       Impact factor: 7.934

4.  Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes.

Authors:  Brian Stevenson; Nazira El-Hage; Melissa A Hines; Jennifer C Miller; Kelly Babb
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Authors:  F T Liang; A C Steere; A R Marques; B J Johnson; J N Miller; M T Philipp
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi.

Authors:  J Hellwage; T Meri; T Heikkilä; A Alitalo; J Panelius; P Lahdenne; I J Seppälä; S Meri
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

7.  Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.

Authors:  A Alitalo; T Meri; L Rämö; T S Jokiranta; T Heikkilä; I J Seppälä; J Oksi; M Viljanen; S Meri
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.

Authors:  P Kraiczy; C Skerka; V Brade; P F Zipfel
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice.

Authors:  Matthew B Lawrenz; R Mark Wooten; James F Zachary; Scott M Drouin; Janis J Weis; Rick A Wetsel; Steven J Norris
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Comprehensive analysis of the factor h binding capabilities of borrelia species associated with lyme disease: delineation of two distinct classes of factor h binding proteins.

Authors:  John V McDowell; Jill Wolfgang; Emily Tran; Michael S Metts; Duncan Hamilton; Richard T Marconi
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.